微生物学研究グループ（後藤・横田）
学 術 論 文
2024
1. Fukushima S, Hagiya H, Gotoh K, Tsuji S, Iio K, Matsushita O. Detection of imported clinical strain of blaNDM-1-harbouring ST147 Klebsiella pneumoniae from a Ukrainian immigrant. J Travel Med. 2024 Jan 17:taae011.
doi: 10.1093/jtm/taae011. Epub ahead of print. PMID: 38236179.
2. Uojima H, Sakaguchi Y, Gotoh K, Satoh T, Hidaka H, Take A, Horio K, Hayashi S, Kusano C. Metabolic dysfunction-associated fatty liver disease on distinct microbial communities at the bacterial phylum level. Dig Dis. 2024;42(1):61-69. doi: 10.1159/000534284.
3. Okanoue S, Sakae H, Yokota K, Tanaka T, Obayashi Y, Abe M, Kono Y, Kanzaki H, Iwamuro M, Kawano S, Kawahara Y, Yanai H, Okada H. Endoscopic and Histological Gastritis in University Students with Helicobacter pylori Infection.
Intern Med. 2024 Mar 4. doi: 10.2169/internalmedicine.1851-23.
2023
1. Také A, Uojima H, Sakaguchi Y, Gotoh K, Satoh T, Hidaka H, Horio K, Mizokami M, Hayashi S, Kusano C. Impact of liver fibrosis on the relative abundance of a urease-positive Streptococcus salivarius group from saliva in patients with chronic liver disease. Hepatol Res. 2023 Jun 6.
doi: 10.1111/hepr.13930.
2. Fukushima S, Hagiya H, Uda K, Gotoh K, Otsuka F. Current Prevalence of Antimicrobial Resistance in Okayama from a National Database between 2018 and 2021. Acta Med Okayama. 2023 Jun;77(3):255-262.
doi: 10.18926/AMO/65490.
3. Nahar L, Hagiya H, Nada T, Iio K, Gotoh K, Matsushita O, Otsuka F. Prevalence of Inducible Macrolide, Lincosamide, and Streptogramin B (inducible MLSB) Resistance in Clindamycin-Susceptible Staphylococcus aureus at Okayama University Hospital. Acta Med Okayama. 2023 Feb;77(1):1-9.
doi: 10.18926/AMO/64355.
4. Takahashi K, Shigeyasu K, Kondo Y, Gotoh K, Yano S, Umeda Y, Inokuchi T, Xu C, Yoshida K, Umeda H, Takahashi T, Takeda S, Yoshida R, Teraishi F, Kishimoto H, Mori Y, Noma K, Okugawa Y, Hiraoka S, Michiue H, Tazawa H, Matsushita O, Goel A, Fujiwara T. RNA Editing is a Valuable Biomarker for Predicting Carcinogenesis in Ulcerative Colitis. J Crohns Colitis. 2023 May 3;17(5):754-766.
doi: 10.1093/ecco-jcc/jjac186.
5. Elfadadny A, Uchiyama J, Goto K, Imanishi I, Ragab RF, Nageeb WM, Iyori K, Toyoda Y, Tsukui T, Ide K, Kawamoto K, Nishifuji K. Antimicrobial resistance and genotyping of Pseudomonas aeruginosa isolated from the ear canals of dogs in Japan. Front Vet Sci. 2023 Jul 20;10:1074127.
doi: 10.3389/fvets.2023.1074127.
6. 【和文】馬生 良則, 崎田 彩弥加, 横山 恵三, 小坂 紀子, 矢野 朋文, 後藤 和義, 萩谷 英大. 海外渡航歴のない患者から検出されたNDM-5産生Escherichia coli. 岡山医学検査 60(1) 13-13 2023年2月
7. 【和文】飯尾 耕治, 後藤 和義, 萩谷 英大, 小川 寛人, 三好 諒, 大塚 文男, 東影 明人. 臨床検査室におけるナノポアシーケンシング技術を用いた新型コロナウイルス感染症の疫学的解析実用化に向けての取り組み. 医学検査 72(2) 248-255 2023年2月 査読有
8. 【和文】倉岡 紗樹子, 横田 憲治, 榮 浩行, 小嶋 日菜子, 岡上 昇太郎, 河野 吉泰, 岡田 裕之. Helicobacter pylori感染胃炎における硝酸塩還元菌の胃内生息状況に関する検討(解説). 日本ヘリコバクター学会誌(2187-8005)24巻2号 Page110-116(2023.01)
2022
1. Watanabe A, Tamaki N, Yokota K, Kokeguchi S, Ito HO, Matsuyama M. Use of ATP Bioluminescence Assay to Evaluate Oral Streptococci. Biocontrol Sci. 2022;27(4):229-233. doi: 10.4265/bio.27.229.
2. Ojima H, Kuraoka S, Okanoue S, Okada H, Gotoh K, Matsushita O, Watanabe A, Yokota K. Effects of Helicobacter pylori and Nitrate-Reducing Bacteria Coculture on Cells. Microorganisms. 2022 Dec 16;10(12):2495. doi: 10.3390/microorganisms10122495.
3. Yokota K, Osaki T, Hayashi S, Yokota SI, Takeuchi H, Rimbara E, Ojima H, Sato T, Yonezawa H, Shibayama K, Tokunaga K, Kamiya S, Murakami K, Kato M, Sugiyama T. Establishment of a reference panel of Helicobacter pylori strains for antimicrobial susceptibility testing. Helicobacter. 2022 Jun;27(3):e12874. doi: 10.1111/hel.12874.
4. Gotoh K, Hagiya H, Iio K, Yamada H, Matsushita O, Otsuka F. Detection of Enterobacter cloacae complex strain with a blaNDM-1-harboring plasmid from an elderly resident at a long-term care facility in Okayama, Japan. J Infect Chemother. 2022 Dec;28(12):1697-1699. doi: 10.1016/j.jiac.2022.08.019.
5. Gotoh K, Sakaguchi Y, Kato H, Osaki H, Jodai Y, Wakuda M, Také A, Hayashi S, Morita E, Sugie T, Ito Y, Ohmiya N. Fecal microbiota transplantation as therapy for recurrent Clostridioides difficile infection is associated with amelioration of delirium and accompanied by changes in fecal microbiota and the metabolome. Anaerobe. 2022 Feb;73:102502. doi: 10.1016/j.anaerobe.2021.102502.
6. Gotoh K, Mayura IPB, Enomoto Y, Iio K, Matsushita O, Otsuka F, Hagiya H. Detection of in-frame mutation by IS30-family insertion sequence in the phospholipid phosphatidylglycerol synthase gene (pgsA2) of high-level daptomycin-resistant Corynebacterium striatum. Eur J Clin Microbiol Infect Dis. 2022 Feb;41(2):331-333. doi: 10.1007/s10096-021-04369-1.
7. Uchiyama J, Takemura-Uchiyama I, Gotoh K, Kato SI, Sakaguchi Y, Murakami H, Fukuyama T, Kaneki M, Matsushita O, Matsuzaki S. Phylogenic analysis of new viral cluster of large phages with unusual DNA genomes containing uracil in place of thymine in gene-sharing network, using phages S6 and PBS1 and relevant uncultured phages derived from sewage metagenomics. Virus Res. 2022 Oct 2;319:198881. doi: 10.1016/j.virusres.2022.198881.
8.【和文】内山淳平、後藤和義、萩谷英大. 研究室配属科目における学部生へのワンヘルス・アプローチに基づく薬剤耐性研究を介したポストコロナ時代の感染症教育の試み. ワンヘルスサイエンス, 4(1); 21-24, 2022 査読有
9. 【和文】大崎 敬子, 横田 憲治, 林 俊治, 横田 伸一, 竹内 啓晃, 柴山 恵吾, 村上 和成, 加藤 元嗣, 杉山 敏郎.
Helicobacter pylori薬剤感受性試験の国内標準化に向けて 耐性菌基準パネルの作成(解説). 日本ヘリコバクター学会耐性菌基準パネル作成部会. 日本ヘリコバクター学会誌(2187-8005)24巻1号 Page44-48, 2022
2021
1. Gotoh K, Miyoshi M, Mayura IPB, Iio K, Matsushita O, Otsuka F, Hagiya H. In vitro effectiveness of biapenem against IMP-producing Enterobacteriaceae. J Med Microbiol. 2021 Oct;70(10). doi: 10.1099/jmm.0.001430.
2. Ichihara A, Ojima H, Gotoh K, Matsushita O, Take S, Okada H, Watanabe A, Yokota K. Serodiagnosis and Bacterial Genome of Helicobacter pylori Infection. Toxins (Basel). 2021 Jul 5;13(7):467. doi: 10.3390/toxins13070467.
3. Kobatake T, Ogino K, Sakae H, Gotoh K, Watanabe A, Matsushita O, Okada H, Yokota K. Antibacterial Effects of Disulfiram in Helicobacter pylori. Infect Drug Resist. 2021 May 12;14:1757-1764. doi: 10.2147/IDR.S299177.
4. Mayura IPB, Gotoh K*, Nishimura H, Nakai E, Mima T, Yamamoto Y, Yokota K, Matsushita O. Elizabethkingia anophelis, an emerging pathogen, inhibits RAW 264.7 macrophage function. Microbiol Immunol. 2021 Aug;65(8):317-324. doi: 10.1111/1348-0421.12888. *Coresponding Author
5. Gotoh K, Mayura IPB, Hagiya H, Obata K, Ogawa T, Iio K, Fujimori T, Otsuka F, Matsushita O. Septic pulmonary emboli caused by Tsukamurella inchonensis: A case report. J Infect Chemother. 2021 Feb;27(2):369-372. doi: 10.1016/j.jiac.2020.09.024.
6. Watanabe A, Watanabe T, Kokeguchi S, Yamamoto Y, Matsushita O, Yokota K. Environmental survey of Methicillin-Resistant Staphylococci in a Hospital in Japan. Biocontrol Sci. 2021;26(3):137-145. doi: 10.4265/bio.26.137.
2020
1. Fatmawati NND, Gotoh K, Mayura IPB, Nocianitri KA, Suwardana GNR, Komalasari NLGY, Ramona Y, Sakaguchi M, Matsushita O, Sujaya IN. Enhancement of intestinal epithelial barrier function by Weissella confusa F213 and Lactobacillus rhamnosus FBB81 probiotic candidates in an in vitro model of hydrogen peroxide-induced inflammatory bowel disease. BMC Res Notes. 2020 Oct 20;13(1):489. doi: 10.1186/s13104-020-05338-1.
2. Sakaguchi Y, Uchiyama J, Také A, Gotoh K, Sakaguchi M, Suzuki T, Yamamoto Y, Hosomi K, Kohda T, Mukamoto M, Kozaki S, Hayashi S, Oguma K. Analysis of a plasmid encoding botulinum neurotoxin type G gene in Clostridium argentinense. Anaerobe. 2020 Dec;66:102281. doi: 10.1016/j.anaerobe.2020.102281.
3. Take S, Mizuno M, Ishiki K, Kusumoto C, Imada T, Hamada F, Yoshida T, Yokota K, Mitsuhashi T, Okada H. Risk of gastric cancer in the second decade of follow-up after Helicobacter pylori eradication. J Gastroenterol. 2020 Mar;55(3):281-288. doi: 10.1007/s00535-019-01639-w.
4. 佐藤 妃映, 横田 憲治, 渡辺 朱理, 苔口 進, 衛藤 友美, 高阪 翔士. 尿沈渣標本中に出現する顆粒状物質と尿路細菌叢との関連について(原著論文). 日本防菌防黴学会誌(2187-431X)48巻12号 Page623-628. 2020